In the fast-paced Lightning Round of Thursday night's Mad Money program, Jim Cramer was bullish on TherapeuticsMD (TXMD) . When I looked at the charts and indicators today I found I came to a much different conclusion, but that is what makes a horse race.
In this daily bar chart of TXMD, below, we can see that prices are in a downtrend from June. Prices are below the declining 50-day and 200-day moving averages. The daily On-Balance-Volume (OBV) line shows a decline which indicates more aggressive selling, even at these low price levels. In the lower panel is the 12-day momentum study which has yet to show a bullish divergence.
In this weekly bar chart of TXMD, we also have a weak picture. Prices are below the declining 40-week moving average line and prices are testing the low of 2017. The weekly OBV line is bearish and the 12-week momentum study is still pointed down.
In this long-term Point and Figure chart of TXMD, below, we can see a large distribution (selling) pattern going back to 2014. A decline to $3.25 would be a new low for the move down and probably precipitate further declines. A rally to $8.00 is needed to turn this chart bullish.
Bottom line strategy: I no nothing about the fundamentals of TXMD but the charts are bearish.